Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$59.70
Day range
$57.00 - $60.20
Year range
$47.70 - $81.32
Market cap
15.20B TWD
Avg Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 46.82M | 175.28% |
Operating expense | 307.11M | -15.29% |
Net income | -340.38M | 7.18% |
Net profit margin | -727.01 | 66.28% |
Earnings per share | — | — |
EBITDA | -271.23M | 19.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 570.97M | -45.13% |
Total assets | 6.89B | 103.49% |
Total liabilities | 2.02B | 5.75% |
Total equity | 4.87B | — |
Shares outstanding | 238.68M | — |
Price to book | 2.92 | — |
Return on assets | -10.99% | — |
Return on capital | -11.65% | — |
Cash Flow
Net change in cash
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -340.38M | 7.18% |
Cash from operations | -328.90M | 3.12% |
Cash from investing | -140.22M | 11.95% |
Cash from financing | -41.84M | -104.11% |
Net change in cash | -506.22M | -196.41% |
Free cash flow | -322.80M | -29.00% |
About
Founded
2013
Website
Employees
200
